Marchiafava-Bignami disease-like lesions due to central nervous system lupus.
Kashiwagi Clinic, Kitakyushu, Japan.
Yoichiro
Y
Kashiwagi
Takahiko
T
Horiuchi
Chie
C
Harashima
Fujio
F
Matsubara
Shin-Ichi
S
Harashima
D000284:Administration, Oral; D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000175:diagnosis / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000097:blood; D003337:Corpus Callosum / Q000473:pathology; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis* / Q000188:drug therapy; D054319:Marchiafava-Bignami Disease / Q000175:diagnosis* / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D009336:Necrosis; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000175:diagnosis; D020551:Pulse Therapy, Drug
D000893:Anti-Inflammatory Agents; D000974:Antibodies, Antinuclear; D011239:Prednisolone; D008775:Methylprednisolone